You need health cover regardless of what you take two at a time - pills or stairs.
Tata AIG Criticare - Critical Illness Policy
The Critical Illness Policy offered by Tata AIG offers insurance cover for 11 critical illnesses with insurance covers ranging from Rs. 2.5 lakhs to Rs. 15 lakhs. It offers features like lifetime renewability and the possibility of enhancing the sum insured when the policy is renewed. It comes with lifelong renewability, as long as the premiums are paid without a break, and the premium paying frequency is annual.
Features & Benefits of Tata AIG Critical Illness Policy:
To be able to buy this policy you need to be between the ages of 18 years and 65 years.
The sum insured can range from Rs. 2.5 lakhs to 15 lakhs
Waiting period for cover for critical illness to begin is 90 days
Survival period is 30 days from the first diagnosis
The policy provides cover for the following 11 critical illnesses
First Heart Attack
Coronary Artery Bypass Graft
Kidney Failure Requiring Dialysis
Major Organ and Bone Marrow Transplant
Loss of sight
The policy comes with a free look period of 15 days.
In case you fail to make premium payments on time you have a grace period of 30 days.
The sum insured can be enhanced when renewing the policy.
The premiums paid towards this policy are eligible for tax benefits under section 80D.
In case you are diagnosed with a critical illness, a second opinion will be covered under this policy.
Pre-existing conditions and resultant complications will not be covered.
Exposure to radioactivity, nuclear material or toxic substances will not be covered.
Complications arising from congenital conditions will not be covered.
All illnesses that are not a part of this policy will not be covered.
Self-inflicted injuries or STDs will also not be covered.
Injuries or illnesses arising from HIV/AIDS or attempted suicide will not be covered.
Other Health Insurance Plans from Tata AIG
Health Insurance by Insurers
reTH65gcmBgCJ7k - pingdom check string.
This Page is BLOCKED as it is using Iframes.